녹아웃(KO) 마우스 | Cyagen Korea

With the upcoming Thanksgiving Holiday in the US – Cyagen would like to thank you for everything you do to make the world a better place.

Researchers have expressed their appreciation for our animal model generation services in recent testimonials – and we couldn’t help but share the love:

Charles A. Dinarello (University of Colorado Denver - Anschutz Medical Campus):

“Using Cyagen’s CRISPR-generated constitutive knockout mice has greatly facilitated our understanding the biology in IL-1 family of 11 cytokines or their respective receptors. We were able to have the IL-38 deficient mice and the IL-1R9 deficient mice in record time. The service provided by Cyagen is highly recommended.”

Young-Jae Nam (Vanderbilt University Medical Center):

“Cyagen made two reporter knock-in mice (i.e. MLC-2v-tdTomato and Nppa-tagBFP) which were used in my recent publications. Both reporters were precisely expressed where and when they should express. Cyagen was very responsive and responsible even after I received the mice. I am sure that I will work with Cyagen again.”

We strive to support your research through our proprietary gene modification technologies, expert support, and guaranteed services – but hearing from satisfied clients gives us so much more to be thankful for.

We would love to hear about your experience working with us. Previous clients who provide a testimonial for Cyagen's services will enjoy an additional discount of 5% off your next order of custom animal model generation projects. Feel free to reply directly with a testimony (2-3 sentences suggested) or to request more information about how we may assist with your next research model.

Thank you for considering us as a partner for enabling your next discovery.

2006 년에 설립된 Cyagen은 데이터, 알고리즘, 모델로 신약 개발을 가속화하는 혁신적인 CRO 기업으로, 동물 모델 맞춤화부터 유전자, 세포 치료 업무에 이르기까지 고객의 요구를 전방위적으로 충족합니다.
카톡 채널 팔로우 클릭
최신 동향을 파악
제품 업무 상담
전화:
86 20-31601779
이메일:
웹 사이트:
  • Contact Us

    영업일 기준 1-2일 내에 답변해 드리겠습니다.

    *

    The username is required

    *

    The user's email is required

    Please enter a valid email address.

    *

    The content is required

    *